172 related articles for article (PubMed ID: 17041566)
21. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical localization of group II phospholipase A2 in colonic mucosa of patients with inflammatory bowel disease.
Minami T; Shinomura Y; Miyagawa J; Tojo H; Okamoto M; Matsuzawa Y
Am J Gastroenterol; 1997 Feb; 92(2):289-92. PubMed ID: 9040208
[TBL] [Abstract][Full Text] [Related]
23. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
[TBL] [Abstract][Full Text] [Related]
24. Disaccharidase activity in children with inflammatory bowel disease.
Wiecek S; Wos H; Radziewicz Winnicki I; Komraus M; Grzybowska Chlebowczyk U
Turk J Gastroenterol; 2014 Apr; 25(2):185-91. PubMed ID: 25003680
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease.
von Lampe B; Barthel B; Coupland SE; Riecken EO; Rosewicz S
Gut; 2000 Jul; 47(1):63-73. PubMed ID: 10861266
[TBL] [Abstract][Full Text] [Related]
26. [Undefined chronic colitis with its patho-histologic differentiation from Crohn disease and ulcerative colitis].
von Herbay A; Sinn P; Otto HF
Z Gastroenterol Verh; 1989 Jul; 24():22-5. PubMed ID: 2474961
[No Abstract] [Full Text] [Related]
27. Expression of heat shock protein 32 (hemoxygenase-1) in the normal and inflamed human stomach and colon: an immunohistochemical study.
Barton SG; Rampton DS; Winrow VR; Domizio P; Feakins RM
Cell Stress Chaperones; 2003; 8(4):329-34. PubMed ID: 15115285
[TBL] [Abstract][Full Text] [Related]
28. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
29. Heparanase expression in Langerhans cell histiocytosis.
Dvir R; Vlodavsky I; Ilan N; Bitan M; Issacov J; Elhasid R
Pediatr Blood Cancer; 2014 Oct; 61(10):1883-5. PubMed ID: 24737657
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus (EBV) infection and expression of the interleukin-12 family member EBV-induced gene 3 (EBI3) in chronic inflammatory bowel disease.
Gehlert T; Devergne O; Niedobitek G
J Med Virol; 2004 Jul; 73(3):432-8. PubMed ID: 15170639
[TBL] [Abstract][Full Text] [Related]
31. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
32. Inflamed intestinal mucosa features a specific epithelial expression pattern of indoleamine 2,3-dioxygenase.
Ferdinande L; Demetter P; Perez-Novo C; Waeytens A; Taildeman J; Rottiers I; Rottiers P; De Vos M; Cuvelier CA
Int J Immunopathol Pharmacol; 2008; 21(2):289-95. PubMed ID: 18547472
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.
Klockars M; Reitamo S; Reitamo JJ; Möller C
Gut; 1977 May; 18(5):377-81. PubMed ID: 326636
[TBL] [Abstract][Full Text] [Related]
34. Intestinal epithelial PKM2 serves as a safeguard against experimental colitis via activating β-catenin signaling.
Sun X; Yao L; Liang H; Wang D; He Y; Wei Y; Ye L; Wang K; Li L; Chen J; Zhang CY; Xu G; Wang F; Zen K
Mucosal Immunol; 2019 Nov; 12(6):1280-1290. PubMed ID: 31462699
[TBL] [Abstract][Full Text] [Related]
35. Mucosal glucosamine synthetase activity in inflammatory bowel disease.
Winslet MC; Poxon V; Allan A; Keighley MR
Dig Dis Sci; 1994 Mar; 39(3):540-4. PubMed ID: 8131690
[TBL] [Abstract][Full Text] [Related]
36. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.
Spieker T; Herbst H
Am J Pathol; 2000 Jul; 157(1):51-7. PubMed ID: 10880375
[TBL] [Abstract][Full Text] [Related]
37. Role of alkaline phosphatase in colitis in man and rats.
Tuin A; Poelstra K; de Jager-Krikken A; Bok L; Raaben W; Velders MP; Dijkstra G
Gut; 2009 Mar; 58(3):379-87. PubMed ID: 18852260
[TBL] [Abstract][Full Text] [Related]
38. Macrophages, nitric oxide and microRNAs are associated with DNA damage response pathway and senescence in inflammatory bowel disease.
Sohn JJ; Schetter AJ; Yfantis HG; Ridnour LA; Horikawa I; Khan MA; Robles AI; Hussain SP; Goto A; Bowman ED; Hofseth LJ; Bartkova J; Bartek J; Wogan GN; Wink DA; Harris CC
PLoS One; 2012; 7(9):e44156. PubMed ID: 22970173
[TBL] [Abstract][Full Text] [Related]
39. Pathology of inflammatory bowel disease.
Gramlich T; Petras RE
Semin Pediatr Surg; 2007 Aug; 16(3):154-63. PubMed ID: 17602970
[TBL] [Abstract][Full Text] [Related]
40. Upregulation of intestinal mucosal mast cells expressing VPAC1 in close proximity to vasoactive intestinal polypeptide in inflammatory bowel disease and murine colitis.
Casado-Bedmar M; Heil SDS; Myrelid P; Söderholm JD; Keita ÅV
Neurogastroenterol Motil; 2019 Mar; 31(3):e13503. PubMed ID: 30407703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
